Elekta treats patients of the present and future

By Admin
Since it was established in Australia in 2004 as a direct subsidiary of its corporate headquarters in Sweden, Elekta Australasia has served the radiatio...

Since it was established in Australia in 2004 as a direct subsidiary of its corporate headquarters in Sweden, Elekta Australasia has served the radiation oncology, medical oncology and neuroscience communities throughout Australia and New Zealand with world-class clinical solutions and services.

The company has worked with several prestigious hospitals in Australia, including the Princess Alexandra Hospital in Brisbane. Among Elekta’s missions are maintaining customer satisfaction.

Click here to read the latest edition of Healthcare Global magazine!

“Our prime focus is establishing high customer satisfaction and meeting customer expectations, and expectations are high in Australia,” said Managing Director Shaun Seery.

Technology and Innovations

Elekta pioneered the 4D CT technique, an imaging workflow that enables doctors to acquire images of moving targets in the body. Accordingly, 4D CT is particularly useful for treating lung cancer, in which tumors can change position with patient breathing.

RELATED TOPIC: The success story of PAML: Pathology Associates Medical Laboratories

Another innovation is the 160-leaf multileaf collimator (MLC), Agility™, a beam-shaping device that is the fastest in the industry. Combined with a High Dose Rate mode, clinicians can use the linear accelerator to treat patients faster and with greater therapeutic effect.

“If you can be more confident where you’re going to deliver the dose, you can deliver a higher dose to the tumor,” said Seery. “With that you’ll be able to hypofractionate for some indications, which would reduce the number of treatments the patient will have to come for.”

RELATED TOPIC: Princess Alexandra Hospital: Nationally recognised for excellence, expertise

According to Seery, the best practice is eliminating the number of required treatments. Instead of having 30-35 treatments, the goal is to bring it down to 10-15. The company prides itself on updating its technology and innovations, but ... Click here to read the rest of the article on Healthcare Global!

Let's connect!   

Share

Featured Articles

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

As researchers report breakthrough on vaccine against MRSA bacteria, we look at which pharmas are working on vaccines to combat antimicrobial resistance

Oracle Fusion Cloud Update Boost for Patients

Oracle Fusion Cloud SCM includes new Healthcare Marketplace solution to help hospitals & clinics optimise planning, automate processes and improve outcomes

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability

WHO Health Chatbot Built on 'Humanised' GenAI

Digital Healthcare

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Medical Devices & Pharma